$VSTR client PhoenixPharmLB has developed a non-addictive painkiller that's poised to disrupt the $35 billion opioid market and has won a $2.7 million grant from the DOD. Join over 800 investors & own a piece of this groundbreaking company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.